Form 4 for HUM Humana
Accepted 2025-05-16 00:00:00 ET · period of report 2025-05-14 · accession 0001062993-25-009705 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-05-16 | 2025-05-14 | HUM | Rechtin James A. | Pres, CEO | P - Purchase | $229.25 | +6,530 | 30.5K | +27% | +$1.50M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Humana Common | 2025-05-14 | P | A | 6,530 | $229.25 | 30,474 | I See Footnote | — | — | (F7) Average price of shares purchased in reported transaction. (F6) Includes 21,761 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. (F1) All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. |